1. Home
  2. GTBP vs YOSH Comparison

GTBP vs YOSH Comparison

Compare GTBP & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • YOSH
  • Stock Information
  • Founded
  • GTBP 1965
  • YOSH 2016
  • Country
  • GTBP United States
  • YOSH United States
  • Employees
  • GTBP N/A
  • YOSH N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • GTBP Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • GTBP Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • GTBP 6.6M
  • YOSH 6.4M
  • IPO Year
  • GTBP N/A
  • YOSH 2022
  • Fundamental
  • Price
  • GTBP $2.91
  • YOSH $3.04
  • Analyst Decision
  • GTBP
  • YOSH
  • Analyst Count
  • GTBP 0
  • YOSH 0
  • Target Price
  • GTBP N/A
  • YOSH N/A
  • AVG Volume (30 Days)
  • GTBP 28.9K
  • YOSH 55.4K
  • Earning Date
  • GTBP 11-14-2024
  • YOSH 11-22-2024
  • Dividend Yield
  • GTBP N/A
  • YOSH N/A
  • EPS Growth
  • GTBP N/A
  • YOSH N/A
  • EPS
  • GTBP N/A
  • YOSH N/A
  • Revenue
  • GTBP N/A
  • YOSH $10,662,741.00
  • Revenue This Year
  • GTBP N/A
  • YOSH N/A
  • Revenue Next Year
  • GTBP N/A
  • YOSH N/A
  • P/E Ratio
  • GTBP N/A
  • YOSH N/A
  • Revenue Growth
  • GTBP N/A
  • YOSH 18.50
  • 52 Week Low
  • GTBP $1.92
  • YOSH $2.73
  • 52 Week High
  • GTBP $10.66
  • YOSH $13.86
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 55.53
  • YOSH 29.54
  • Support Level
  • GTBP $2.94
  • YOSH $2.73
  • Resistance Level
  • GTBP $3.54
  • YOSH $5.25
  • Average True Range (ATR)
  • GTBP 0.27
  • YOSH 0.91
  • MACD
  • GTBP -0.02
  • YOSH -0.16
  • Stochastic Oscillator
  • GTBP 23.05
  • YOSH 7.91

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: